CD137-mediated immunotherapy for allergic asthma
Authors:
- Juergen FoellJFJuergen Foell
- Christoph WernerCWChristoph Werner
- Heinz-Gerd HoymannHHHeinz-Gerd Hoymann
- Armin BraunABArmin Braun
- Stefan BurdachSBStefan Burdach
- Obert S. MittlerOMObert S. Mittler
- Gesine HansenGHGesine Hansen
Open Access
- 3 April 2006
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (4) , 1025-1036
Abstract
The prevalence of asthma continues to increase. Asthma is caused by a Th2 cell–driven immune response. Its optimal treatment remains a challenge, and a sufficient immunotherapeutic approach to treating asthma has yet to be found. Using a murine asthma model, we show that a single injection of an anti-CD137 (4-1BB) mAb prevents the development of airway hyperreactivity, eosinophilic airway inflammation, excessive mucus production, and elevated IgE during the observation period of 7 weeks. Most importantly, even established disease is completely reversed by anti-CD137 mAb administration. The protection is associated with markedly reduced Th2 cytokine production and increased secretion of the Th1 cytokine IFN-γ. While B lymphocytes are partly depleted, the number of CD8+ T cells is increased. Blockade of IFN-γ and depletion of CD8+ T cells during treatment with anti-CD137 mAb reduces in part but does not abrogate the protective effect of CD137 mAb. In contrast, CD137 mAb–mediated CD4+ T cell anergy is critical for the observed effects, since transfer of CD4+ T cells from CD137 mAb–treated mice conveyed protection. These data demonstrate, for the first time to our knowledge, the capacity of anti-CD137 mAb to ameliorate allergic asthma, and they indicate CD137 as a possible target for therapeutic intervention in this disease.Keywords
This publication has 49 references indexed in Scilit:
- Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing miceJournal of Applied Physiology, 2004
- Unifying concepts in CD28, ICOS and CTLA4 co-receptor signallingNature Reviews Immunology, 2003
- In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responsesNature Immunology, 2002
- Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non–IgE-mediated eosinophilic disordersJournal of Allergy and Clinical Immunology, 2001
- AsthmaNew England Journal of Medicine, 2001
- Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell AnergyJournal of Experimental Medicine, 1999
- Cytokines in asthmaThorax, 1999
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989